NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Net Income Including Noncontrolling Interests : $-176.94 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

NewAmsterdam Pharma Co NV's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was $-95.32 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was $-176.94 Mil.

NewAmsterdam Pharma Co NV Net Income Including Noncontrolling Interests Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Net Income Including Noncontrolling Interests Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Income Including Noncontrolling Interests

-7.07

-41.79

-22.63

-176.94

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial			-30.50	56.94	-79.58	-81.62	-95.32

NewAmsterdam Pharma Co NV Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-176.94 Mil.

NewAmsterdam Pharma Co NV Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.